Defining the Molecular Landscape of Ependymomas
Overview
Authors
Affiliations
Ependymomas have a variable prognosis. In this issue of Cancer Cell, Pajtler and colleagues identify nine subgroups of ependymoma using DNA methylation profiles. Two subgroups, predominately pediatric, are responsible for most of the mortality, with all others having nearly 100% overall survival after 5 years.
Mastantuoni C, Tortora F, Tafuto R, Tortora M, Briganti F, Franca R Brain Sci. 2022; 12(9).
PMID: 36138961 PMC: 9497216. DOI: 10.3390/brainsci12091227.
Brown N, Wilson B, Lien B, Himstead A, Tafreshi A, Shahrestani S Neurosurg Rev. 2021; 45(2):1041-1088.
PMID: 34613526 PMC: 8976812. DOI: 10.1007/s10143-021-01579-1.
Case Report: Sellar Ependymomas: A Clinic-Pathological Study and Literature Review.
Zhao L, Jiang Y, Wang Y, Bai Y, Liu L, Li Y Front Endocrinol (Lausanne). 2021; 12:551493.
PMID: 34168614 PMC: 8218727. DOI: 10.3389/fendo.2021.551493.
Massimino M, Barretta F, Modena P, Witt H, Minasi S, Pfister S Neuro Oncol. 2020; 23(5):848-857.
PMID: 33135735 PMC: 8099475. DOI: 10.1093/neuonc/noaa257.
Supratentorial pediatric cortical ependymomas: a comprehensive retrospective study.
Wang Q, Cheng J, Zhang S, Li Q, Hui X, Ju Y Neurosurg Rev. 2020; 44(3):1543-1551.
PMID: 32607870 DOI: 10.1007/s10143-020-01336-w.